Your Notifications
All done, no notifications
Dr. Professor Li Jin

Dr. Professor Li Jin

Medical Oncologist

, Shanghai, China

40 Years of experience

Speaks: Chinese,English

USD 700 USD 650 for video consultation

Chat
Book Video Consultation

About Dr. Professor Li Jin

  • As a prominent authority in the multidisciplinary management of complex solid tumors, Professor Li Jin has contributed greatly to China's global standing in terms of clinical oncology research.
  • As of October 2023, Professor Li Jin is regarded as a respected oncologist. As an academic leader and a pioneer in clinical research, he is known for his contributions to gastrointestinal tumors. He currently holds several titles: Chief Scientist, Academic Leader, Chief Physician, Professor, and Doctoral Supervisor.
  • In his nearly forty years of experience as a physician, Professor Li Jin has made important contributions in the areas of molecular targeted therapies, immunotherapy, and early-phase clinical trials.

Conditions treated by Professor Li Jin

  • Gastric cancer
  • Colorectal cancer
  • Esophageal cancer
  • Pancreatic cancer
  • Liver cancer
  • Other malignant gastrointestinal tumors
  • Advanced and refractory solid tumors

Area of Interest

  • Molecular targeted therapy for gastrointestinal malignancies
  • Tumor immunotherapy
  • Early-phase (Phase I–III) clinical trials of new anti-cancer drugs
  • Precision oncology and individualised treatment strategies
  • Multidisciplinary diagnosis and treatment (MDT) of complex solid tumors
  • Translational and clinical oncology research

Qualification

  • Graduated from Southeast University School of Medicine (1982)
  • Master’s and Doctoral degrees from the Second Military Medical University
  • Postdoctoral research in tumor gene therapy and biotherapy at Yale University (2000–2002)

Work Experiences

  • Former Director, Department of Medical Oncology, Fudan University Cancer Hospital
  • Former Director, Department of Medical Oncology, Shanghai Tongji University Affiliated Oriental Hospital
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Professor Li Jin on our platform

Consult Online

CERTIFICATIONS (1)

  • Postdoctoral Research Fellow (Yale University, USA)

MEMBERSHIPS (10)

  • President, Asian Federation of Oncology (FACO)
  • Former President, Chinese Society of Clinical Oncology (CSCO)
  • Chairman, Anti-tumor Clinical Research Committee, China Pharmaceutical Promotion Association
  • Deputy Director, Continuing Education and Capacity Building Committee, National Health Commission
  • Chairman, Beijing CSCO Clinical Oncology Research Foundation
  • Chairman, Gastric Cancer Expert Committee, CSCO
  • Chairman-elect, Artificial Intelligence Committee, CSCO
  • Vice Chairman, Abdominal Tumor Committee, Chinese Association for Continuing Medical Education
  • Chairman, Shanghai Waigaoqiao Cell and Gene Therapy Industry Alliance
  • Associate Editor, Cancer Science

RESEARCH PAPERS AND PUBLICATIONS (2)

  • Published 150+ papers in internationally renowned journals including: JAMA, Journal of Clinical Oncology, Lancet Oncology, PNAS, and Clinical Cancer Research
  • Over 100 publications as first or corresponding author

Share Your Experience about Dr. Professor Li Jin

Write Your Review

PROCEDURES

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy

FREQUENTLY ASKED QUESTIONS

Is Professor Li Jin doing teleconsultation on the MediGence platform?
Professor Li Jin is available to teleconsult on the MediGence platform.
How long is the consultation?
The consultation typically lasts between 15 and 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.
How soon can the consultation be organised?
We have Medical specialists and board-certified doctors on our panel. The consultation will be organised within 24 to 48 hours, or based on the doctor's and patient's availability.
Is a follow-up consultation included in the consultation price?
No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.
How do I share my medical record with the doctor for review?
The option to share your medical records is available at the form steps on the website.
Can I book my procedure with the doctor post-consultation?
Yes. If you are satisfied with the consultation, you can proceed with treatment packages tailored to your diagnosis, assisted by our case managers.
Can you get an estimate for the procedure?
Yes. The cost estimate will be provided to you by our case manager, which will include the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Medical Oncologist

What is a gastrointestinal oncologist?
A gastrointestinal oncologist is a specialist in diagnosing and treating cancers of the gastrointestinal (GI) tract using systemic treatment options including chemotherapy, targeting therapy, and immunotherapeutics.
What types of cancers do gastrointestinal oncologists treat?
Gastrointestinal oncologists care for patients with cancers of the GI tract, such as stomach cancer, colon cancer, pancreas cancer, liver cancer, esophageal cancer, as well as other solid tumors that develop in the abdomen.
How do target therapies and immunotherapies enhance cancer treatment?
Targeted and immunotherapy are approaches that target specific pathways or immune mechanisms, making treatment more effective and reducing side effects.
What does a multi-disciplinary approach look like when treating a patient with cancer?
A multidisciplinary approach to treating a patient with cancer involves a team of oncologists, surgeons, radiologists, pathologists, and other specialists working together to develop a personalised treatment plan.
Will patients with cancer benefit from clinical trials?
Yes, patients participating in clinical trials have access to newer therapies that will help establish a better standard of care for treating cancer globally.

Reviewer

Dr. Vishwas Kaushik
Dr. Vishwas Kaushik

MBBS, MD

7 Years of Experience

Dr. Vishwas Kaushik is a qualified medical professional holding an MBBS from the prestigious Belgorod State University, Russia, with a strong foundation in clinical medicine and healthcare practice. His comprehensive medical training has equipped him with a profound understanding of evidence-based clinical practices, patient-centered care, and the evolving landscape of modern medicine. With a keen interest in medical research and scientific communication, he consistently translates complex clinical concepts into clear, accurate, and accessible content for diverse audiences. His work reflects a deep commitment to advancing medical knowledge, delivering impactful healthcare insights, and bridging the gap between clinical expertise and accessible medical communication. View More

Last Reviewed - January 2026

Author

Dr. Shagufta Parveen
Dr. Shagufta Parveen

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

. View More